Ortin Laboratories Limited SHARE PRICE [LIVE]

BSE: 539287
To view real time prices Login to your account
Already an existing customer? - Login Now!
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
Div yield:

Fundamental analysis


0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Underperformed both Sector by -14.46% and Sensex by -29.69%
MARKET CAP (Micro Cap Stock)Rs 19 Cr
PE (TTM) -19.19
PE Ratio-19.19
Price to Book Value1.75
EV to EBIT-24.74
EV to EBITDA-24.74
EV to Capital Employed1.50
EV to Sales3.36
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)0.48%
ROE (Latest)-8.12%
NameDec 22Sep 22
Promoters (Change:0.00) 15.68%15.68%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0%0%
Non Institution (Change:-0.00) 84.32%84.32%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Ortin Laboratories Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %


Frequently Asked Questions

What is the Share price of Ortin Laboratories Limited (ORTINLAB)?

Ortin Laboratories Limited (ORTINLAB) share price as of February 8, 2023, on NSE is Rs 23.45 (NSE) and Rs 23.50 (BSE) on BSE.

Can I buy Ortin Laboratories Limited (ORTINLAB) shares?

Yes, You can buy Ortin Laboratories Limited (ORTINLAB) shares by opening a Demat account with Angel One.

How do I buy Ortin Laboratories Limited (ORTINLAB) from Angel One?

Ortin Laboratories Limited (ORTINLAB) share can be brought through the following modes:
  1. Direct investment: You can buy Ortin Laboratories Limited (ORTINLAB) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ortin Laboratories Limited (ORTINLAB) shares.


Today's live share price for Ortin Laboratories Limited is NSE: ₹ 23.45, BSE: ₹ 23.50 with a current market capitalization of .

Ortin Laboratories Ltd is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations. The company is an ISO 9001: 2000 certified company. They offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs. Ortin Laboratories Ltd, a Trusted Reliance for Quality was incorporated in the year 1986 as a private limited company with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. In the year 1994, the company was converted into a public limited company. The company constructed a Factory in a spacious area of 25,000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. During the year 2003-04, the company started their second division of products and marketing in few states. During the year 2006-07, the company got listed their shares in BSE- Indonext model, which provided a nation-wide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries. During the year 2009-10, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda. During the year 2010-11, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers